Vanda Pharmaceuticals (VNDA) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -157.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.29% |
| Dec 31, 2025 | -182.66% |
| Sep 30, 2025 | -107.45% |
| Jun 30, 2025 | -132.06% |
| Mar 31, 2025 | -66.15% |
| Dec 31, 2024 | -39.06% |
| Sep 30, 2024 | -39.04% |
| Jun 30, 2024 | -35.14% |
| Mar 31, 2024 | -35.38% |
| Dec 31, 2023 | -31.84% |
| Sep 30, 2023 | -71.55% |
| Jun 30, 2023 | -44.42% |
| Mar 31, 2023 | 87.97% |
| Dec 31, 2022 | 17.45% |
| Sep 30, 2022 | -68.10% |
| Jun 30, 2022 | -39.20% |
| Mar 31, 2022 | -119.02% |
| Dec 31, 2021 | -11.98% |
| Sep 30, 2021 | 2.75% |
| Jun 30, 2021 | 27.93% |
| Mar 31, 2021 | 41.30% |
| Dec 31, 2020 | 86.29% |
| Sep 30, 2020 | 48.99% |
| Jun 30, 2020 | 97.16% |
| Mar 31, 2020 | 27.31% |
| Dec 31, 2019 | 118.77% |
| Sep 30, 2019 | 517.57% |
| Jun 30, 2019 | 65.05% |
| Mar 31, 2019 | 63.28% |
| Dec 31, 2018 | 39.20% |
| Sep 30, 2018 | 40.11% |
| Jun 30, 2018 | 41.69% |
| Mar 31, 2018 | 31.96% |
| Dec 31, 2017 | -26.54% |
| Sep 30, 2017 | -46.47% |
| Jun 30, 2017 | 58.57% |
| Mar 31, 2017 | 33.95% |
| Dec 31, 2016 | 59.67% |
| Sep 30, 2016 | 56.92% |
| Jun 30, 2016 | -10.93% |
| Mar 31, 2016 | -39.84% |
| Dec 31, 2015 | -39.80% |
| Sep 30, 2015 | -21.45% |
| Jun 30, 2015 | 11.99% |
| Mar 31, 2015 | -8.94% |
| Dec 31, 2014 | 144.51% |
| Sep 30, 2014 | 22.19% |
| Jun 30, 2014 | -152.45% |
| Mar 31, 2014 | -481.96% |
| Dec 31, 2013 | -67.88% |
| Sep 30, 2013 | -54.52% |
| Jun 30, 2013 | -66.83% |